Metastasis to lateral lymph nodes with no mesenteric lymph node involvement in low rectal cancer: a retrospective case s
- PDF / 257,779 Bytes
- 4 Pages / 595.276 x 790.866 pts Page_size
- 66 Downloads / 232 Views
(2020) 18:288
RESEARCH
Open Access
Metastasis to lateral lymph nodes with no mesenteric lymph node involvement in low rectal cancer: a retrospective case series Peng Li, Zhichun Zhang, Yuanda Zhou, Qingsheng Zeng, Xipeng Zhang*† and Yi Sun*†
Abstract Purpose: The aim of this study is to examine the pattern of lymph node metastasis (lateral vs. mesenteric lymph nodes) in low rectal cancer. Methods: This retrospective analysis included all patients undergoing laparoscopic total mesorectal excision plus lateral lymph node dissection for advanced low rectal cancer (up to 8 cm from the anal verge) during a period from July 1, 2017, to August 31, 2019, at the Department of Colorectal Surgery, Tianjin Union Medical Center. The decision to conduct lateral lymph node dissection was based on positive findings in preoperative imaging assessments. Results: A total of 42 patients were included in data analysis. Surgery was successfully completed as planned, without conversion to open surgery in any case. A minimum of 10 mesenteric lymph nodes and 1 lateral lymph node on each side were dissected in all patients. Pathologic examination of resected specimens showed no metastasis to either mesenteric or lateral lymph nodes in 7 (16.7%) case, metastasis to both mesenteric and lateral lymph nodes in 26 (61.9%) cases, metastasis to mesenteric but not lateral lymph nodes in 4 (9.5%) cases, and metastasis to lateral but not mesenteric lymph nodes in 5 (11.9%) cases (n = 2 in the obturator region; n = 3 in the iliac artery region). Conclusion: A clinically significant proportion of low rectal cancer patients have metastasis to lateral lymph nodes without involvement of mesenteric lymph nodes. More carefully planned prospective studies are needed to verify this preliminary finding.
Introduction In patients with low rectal cancer (up to 8 cm from the anal verge), estimated rate of lateral lymph node metastasis is 16–23% [1]. The most recent Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines for the treatment of colorectal cancer classify metastasis to lateral lymph nodes as local metastasis and recommend lateral lymph node dissection (LLND) in both stage II and III low rectal cancers [2]. The NCCN Guidelines recommend chemoradiotherapy (CRT) plus total mesorectal excision (TME) treatment for lateral lymph node metastasis * Correspondence: [email protected]; [email protected] † Xipeng Zhang and Yi Sun contributed equally to this work. Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin 300000, China
[3]. A recent study reported 19.5% 5-year local recurrence rate after CRT plus TME versus 5.5% 5-year local recurrence rate after CRT plus TME and LLND in patients with lateral lymph nodes at least 7 mm in diameter, supporting the notion that lateral lymph node involvement represents local metastasis [4]. In this retrospective analysis, we examined the metastasis profile (lateral vs. mesenteric lymph nodes) in a group of low rectal cancer patients with suspected lateral lymph node involvement b
Data Loading...
